Oximio in the Middle East
Through our GMP facility in Israel, GDP Depot in Turkey and audited local Depot Partners in Egypt and Lebanon we provide access to 207 million patients of Middle East. With Oximio broad range of services and deep expertise, we are ready to tailor a supply strategy to fit your trial requirements.
Our Service Coverage in the Middle East:
Partner Depot Kenya